Elekta (OTCMKTS:EKTAY) Shares Gap Up – Should You Buy?

Elekta AB (OTCMKTS:EKTAY) gapped up prior to trading on Friday . The stock had previously closed at $6.57, but opened at $6.93. Elekta shares last traded at $6.86, with a volume of 1,048 shares changing hands.

Elekta Price Performance

The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04. The company has a market capitalization of $2.53 billion, a price-to-earnings ratio of 98.01 and a beta of 1.04. The company has a 50-day moving average price of $5.68 and a 200-day moving average price of $5.25.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, November 26th. The company reported $0.07 EPS for the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.14%. The firm had revenue of $427.85 million during the quarter, compared to the consensus estimate of $436.91 million. On average, equities research analysts expect that Elekta AB will post 0.36 EPS for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.